CN109077317A - A kind of lycopene capsules and preparation method thereof - Google Patents
A kind of lycopene capsules and preparation method thereof Download PDFInfo
- Publication number
- CN109077317A CN109077317A CN201810794340.4A CN201810794340A CN109077317A CN 109077317 A CN109077317 A CN 109077317A CN 201810794340 A CN201810794340 A CN 201810794340A CN 109077317 A CN109077317 A CN 109077317A
- Authority
- CN
- China
- Prior art keywords
- lycopene
- parts
- capsule
- powder
- starch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 title claims abstract description 66
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 title claims abstract description 66
- 239000001751 lycopene Substances 0.000 title claims abstract description 66
- 235000012661 lycopene Nutrition 0.000 title claims abstract description 66
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 title claims abstract description 66
- 229960004999 lycopene Drugs 0.000 title claims abstract description 66
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 title claims abstract description 66
- 239000002775 capsule Substances 0.000 title claims abstract description 59
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 48
- 239000000843 powder Substances 0.000 claims abstract description 34
- 241000894006 Bacteria Species 0.000 claims abstract description 25
- 229920002472 Starch Polymers 0.000 claims abstract description 24
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 24
- 239000008107 starch Substances 0.000 claims abstract description 24
- 235000019698 starch Nutrition 0.000 claims abstract description 24
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 238000012216 screening Methods 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 10
- 238000012797 qualification Methods 0.000 claims description 9
- 239000011812 mixed powder Substances 0.000 claims description 8
- 238000003556 assay Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 238000005498 polishing Methods 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 229920001903 high density polyethylene Polymers 0.000 claims description 2
- 239000004700 high-density polyethylene Substances 0.000 claims description 2
- 238000002372 labelling Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 238000003860 storage Methods 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 7
- 210000004369 blood Anatomy 0.000 abstract description 5
- 239000008280 blood Substances 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 4
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 2
- 238000010521 absorption reaction Methods 0.000 abstract description 2
- 230000003064 anti-oxidating effect Effects 0.000 abstract description 2
- 230000035558 fertility Effects 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract description 2
- 150000002632 lipids Chemical class 0.000 abstract description 2
- 230000001900 immune effect Effects 0.000 abstract 1
- 239000003292 glue Substances 0.000 description 6
- 239000003094 microcapsule Substances 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 210000004100 adrenal gland Anatomy 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 210000002307 prostate Anatomy 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 240000001970 Raphanus sativus var. sativus Species 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000002864 food coloring agent Nutrition 0.000 description 1
- 235000019249 food preservative Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000005296 lung carcinoma Diseases 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a kind of lycopene capsules and preparation method thereof, the present invention is with peacilomyce hepiahi bacterium filament powder, lycopene, starch, magnesium stearate is raw material, prepare a kind of lycopene capsules, the result shows that peacilomyce hepiahi bacterium filament powder, lycopene, starch, magnesium stearate compositions get up, lycopene capsules have good health-care effect to human body, lycopene capsules have content high, the advantages that bioactivity is high, human immunological competence can be remarkably reinforced, with strong anti-oxidation, promote cytothesis, adjust blood lipid, prevent cardiovascular disease, improve male fecundity, improve absorption of human body utilization rate, capsule stability is good, ingredient is hardly damaged, have the characteristics that carry simultaneously convenient to take.
Description
Technical field
The present invention relates to field of health care food, more particularly to a kind of lycopene capsules and preparation method thereof.
Background technique
Lycopene is widely present in the various organs and tissue of human body, is mainly distributed on the blood, adrenal gland, liver of people
In the organs such as dirty, testis, prostate, mammary gland, ovary, uterus, alimentary canal, wherein blood, adrenal gland, liver, testis etc. contain
More lycopene.Lycopene has very superior physiological function.Its rate constant for removing singlet oxygen is current
100 times of common antioxidant vitamin E, are as many as twice of β-carrotene.Lycopene is the strongest class of inoxidizability
Carrotene.Lycopene can effectively prevent prostate cancer, be significantly higher than β-Hu to uterine cancer, the inhibiting effect of lung carcinoma cell
Radish element, α-carrotene.Moreover, the content of lycopene and the service life of people are related in human body.Lycopene, which also has, inhibits low
The oxidation of density fat albumen and uvioresistant effect.It is a kind of up-and-coming functional natural colorants, lycopene is mesh
The strongest antioxidant found on former world, referred to as " plant gold ".There are many lycopene products currently on the market, but
It all comes with some shortcomings: such as using tablet, the product of hard capsule and particle dosage form, the easy oxygen of principle active component lycopene
Change and causes properties of product unstable, it is improper using each component ratio of product content object of soft capsule dosage form, so as to cause content
Object is easily layered, and influences product quality；Contain some synthetic food colors and preservative in capsule material, long-term use can generate human body
Certain side effect.
Summary of the invention
The object of the invention is that providing a kind of lycopene capsules and preparation method thereof to solve the above-mentioned problems.
The present invention through the following technical solutions to achieve the above objectives:
A kind of lycopene capsules, the bulk pharmaceutical chemicals including following weight,
Peacilomyce hepiahi bacterium filament powder: 81-85 parts；
Lycopene: 8-12 parts；
Starch: 5-8 parts；
Magnesium stearate: 0.2-0.5 parts.
Preferably, lycopene capsules, the bulk pharmaceutical chemicals including following weight,
Peacilomyce hepiahi bacterium filament powder: 83 parts；
Lycopene: 10 parts；
Starch: 6 parts；
Magnesium stearate: 0.3 part.
The preparation method of lycopene capsules, comprising the following steps:
Step 1: lycopene, peacilomyce hepiahi bacterium filament powder, starch, magnesium stearate are sloughed after the assay was approved outer
Packaging enters clean area；
Step 2: lycopene, peacilomyce hepiahi bacterium filament powder, starch, magnesium stearate are passed through into 60 meshes sieve respectively
Choosing；
Step 3: material after being sieved is weighed by formula ratio；
Step 4: all formula ratio materials being placed in mixing machine and are mixed 20 minutes, mixed powder is obtained, spare；
Step 5: Autocapsulefillingmachine filling 0 is used#Capsule, filling specification are 0.45g/；
Step 6: the capsule for filling qualification, which is set in capsule polisher, to be polished, and surface medicinal powder is removed；
Step 7: capsule subpackage entrance solid medicinal high-density polyethylene bottle, 60 every bottle；
Step 8: labeling, vanning；
Step 9: finished product is through after the assay was approved, being put in storage.
Preferably, the screening of step 2, the weighing of step 3, the mixing of step 4, the filling of step 5, the throwing of step 6
Light, step 7 inner packing process produce specification GB17405-1998 require (300,000 grades) production clean area under the conditions of grasp
Make.
Preferably, after the screening of step 2 powder diameter less than 250 microns.
Preferably, the filling qualification capsule of step 6 carries out polishing 5-8 minutes in capsule polisher.
Compared with the existing technology, advantages of the present invention is as follows:
The present invention prepares a kind of kind using peacilomyce hepiahi bacterium filament powder, lycopene, starch, magnesium stearate as raw material
Lycopene capsule, peacilomyce hepiahi bacterium are derived from the essence and core effective component of cordyceps sinensis, have obvious inhibition of pain,
Inhibit inflammation, anticancer, enhance human immunity, effect for reducing blood fat, lycopene has effective protection prostate, raising sperm living
Power, improvement infertility, superpower anti-oxidant, raising immunity, protection angiocarpy, removing free radical, extremely strong antialcoholism action.
The lycopene capsules of the content of present invention object have many advantages, such as that content is high, bioactivity is high, do not add any pigment
And preservative, safety is good, has strong anti-oxidation, promotes cytothesis, adjusts blood lipid, prevents cardiovascular disease, improves male
Fecundity improves absorption of human body utilization rate, and capsule stability is good, and ingredient is hardly damaged, while having carrying convenient to take
Feature.
Specific embodiment
The present invention is further illustrated combined with specific embodiments below, but the invention is not limited to these to implement
Example.
Embodiment 1:
A kind of preparation method of lycopene capsules, comprising the following steps:
Composition of raw materials: peacilomyce hepiahi bacterium filament powder: 81 parts；Lycopene: 8 parts；Starch: 5 parts；Magnesium stearate: 0.2
Part；
Lycopene, peacilomyce hepiahi bacterium filament powder, starch, magnesium stearate are passed through into the screening of 60 meshes respectively, will be matched
Side's amount material, which is respectively placed in mixing machine, to be mixed 20 minutes, mixed powder is obtained, later using Autocapsulefillingmachine filling 0#Glue
Capsule, filling specification are 0.45g/, and the capsule for filling qualification, which is set in capsule polisher, to be polished, and remove surface medicinal powder, obtain
Lycopene microcapsule.
Embodiment 2:
A kind of preparation method of lycopene capsules, comprising the following steps:
Composition of raw materials: peacilomyce hepiahi bacterium filament powder: 82 parts；Lycopene: 9 parts；Starch: 6 parts；Magnesium stearate: 0.3
Part；
Lycopene, peacilomyce hepiahi bacterium filament powder, starch, magnesium stearate are passed through into the screening of 60 meshes respectively, will be matched
Side's amount material, which is respectively placed in mixing machine, to be mixed 15 minutes, mixed powder is obtained, later using Autocapsulefillingmachine filling 0#Glue
Capsule, filling specification are 0.45g/, and the capsule for filling qualification, which is set in capsule polisher, to be polished, and remove surface medicinal powder, obtain
Lycopene microcapsule.
Embodiment 3:
A kind of preparation method of lycopene capsules, comprising the following steps:
Composition of raw materials: peacilomyce hepiahi bacterium filament powder: 83 parts；Lycopene: 10 parts；Starch: 7 parts；Magnesium stearate:
0.4 part；
Lycopene, peacilomyce hepiahi bacterium filament powder, starch, magnesium stearate are passed through into the screening of 60 meshes, general kind respectively
Lycopene, peacilomyce hepiahi bacterium filament powder, starch, magnesium stearate pass through the screening of 60 meshes respectively, and formula ratio material is distinguished
It is placed in mixing machine and mixes 20 minutes, obtain mixed powder, later using Autocapsulefillingmachine filling 0#Capsule, filling specification are
0.45g/, the capsule for filling qualification, which is set in capsule polisher, to be polished, and is removed surface medicinal powder, is obtained the micro- glue of lycopene
Capsule.
Embodiment 4:
A kind of preparation method of lycopene capsules, comprising the following steps:
Composition of raw materials: peacilomyce hepiahi bacterium filament powder: 84 parts；Lycopene: 12 parts；Starch: 8 parts；Magnesium stearate:
0.5 part；
Lycopene, peacilomyce hepiahi bacterium filament powder, starch, magnesium stearate are passed through into the screening of 60 meshes respectively, will be matched
Side's amount material, which is respectively placed in mixing machine, to be mixed 25 minutes, mixed powder is obtained, later using Autocapsulefillingmachine filling 0#Glue
Capsule, filling specification are 0.45g/, and the capsule for filling qualification, which is set in capsule polisher, to be polished, and remove surface medicinal powder, obtain
Lycopene microcapsule.
Embodiment 5:
A kind of preparation method of lycopene capsules, comprising the following steps:
Composition of raw materials: peacilomyce hepiahi bacterium filament powder: 85 parts；Lycopene: 9 parts；Starch: 6 parts；Magnesium stearate: 0.3
Part；
Lycopene, peacilomyce hepiahi bacterium filament powder, starch, magnesium stearate are passed through into the screening of 60 meshes respectively, will be matched
Side's amount material, which is respectively placed in mixing machine, to be mixed 15 minutes, mixed powder is obtained, later using Autocapsulefillingmachine filling 0#Glue
Capsule, filling specification are 0.45g/, and the capsule for filling qualification, which is set in capsule polisher, to be polished, and remove surface medicinal powder, obtain
Lycopene microcapsule.
Embodiment 6:
A kind of preparation method of lycopene capsules, comprising the following steps:
Composition of raw materials: peacilomyce hepiahi bacterium filament powder: 85 parts；Lycopene: 11 parts；Starch: 8 parts；Magnesium stearate:
0.2 part；
Lycopene, peacilomyce hepiahi bacterium filament powder, starch, magnesium stearate are passed through into the screening of 60 meshes respectively, will be matched
Side's amount material, which is respectively placed in mixing machine, to be mixed 20 minutes, mixed powder is obtained, later using Autocapsulefillingmachine filling 0#Glue
Capsule, filling specification are 0.45g/, and the capsule for filling qualification, which is set in capsule polisher, to be polished, and remove surface medicinal powder, obtain
Lycopene microcapsule.
Embodiment described above only expresses several embodiments of the invention, and the description thereof is more specific and detailed, but not
Therefore energy is interpreted as the limitation of the invention patent range.It should be pointed out that for those of ordinary skill in the art,
Without departing from the inventive concept of the premise, various modifications and improvements can be made, these belong to protection model of the invention
It encloses.
Claims (6)
1. a kind of lycopene capsules, it is characterised in that: the bulk pharmaceutical chemicals including following weight,
Peacilomyce hepiahi bacterium filament powder: 81-85 parts；
Lycopene: 8-12 parts；
Starch: 5-8 parts；
Magnesium stearate: 0.2-0.5 parts.
2. a kind of lycopene capsules according to claim 1, it is characterised in that: the raw material including following weight
Medicine,
Peacilomyce hepiahi bacterium filament powder: 83 parts；
Lycopene: 10 parts；
Starch: 6 parts；
Magnesium stearate: 0.3 part.
3. -2 described in any item a kind of preparation methods of lycopene capsules according to claim 1, it is characterised in that: including with
Lower step:
Step 1: lycopene, peacilomyce hepiahi bacterium filament powder, starch, magnesium stearate are sloughed into outer packing after the assay was approved
Into clean area；
Step 2: lycopene, peacilomyce hepiahi bacterium filament powder, starch, magnesium stearate are passed through into the screening of 60 meshes respectively；
Step 3: material after being sieved is weighed by formula ratio；
Step 4: all formula ratio materials being placed in mixing machine and are mixed 20 minutes, mixed powder is obtained, spare；
Step 5: Autocapsulefillingmachine filling 0 is used#Capsule, filling specification are 0.45g/；
Step 6: the capsule for filling qualification, which is set in capsule polisher, to be polished, and surface medicinal powder is removed；
Step 7: capsule subpackage entrance solid medicinal high-density polyethylene bottle, 60 every bottle；
Step 8: labeling, vanning；
Step 9: finished product is through after the assay was approved, being put in storage.
4. a kind of preparation method of lycopene capsules according to claim 3, it is characterised in that: the screening of step 2,
The weighing of step 3, the mixing of step 4, the filling of step 5, the polishing of step 6, step 7 inner packing process producing
It is operated under the conditions of the production clean area of specification GB17405-1998 requirement (300,000 grades).
5. a kind of preparation method of lycopene capsules according to claim 3, it is characterised in that: after the screening of step 2
Powder diameter is less than 250 microns.
6. a kind of preparation method of lycopene capsules according to claim 3, it is characterised in that: the filling of step 6 is closed
Lattice capsule carries out polishing 5-8 minutes in capsule polisher.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810794340.4A CN109077317A (en) | 2018-07-19 | 2018-07-19 | A kind of lycopene capsules and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810794340.4A CN109077317A (en) | 2018-07-19 | 2018-07-19 | A kind of lycopene capsules and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109077317A true CN109077317A (en) | 2018-12-25 |
Family
ID=64837849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810794340.4A Pending CN109077317A (en) | 2018-07-19 | 2018-07-19 | A kind of lycopene capsules and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109077317A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101088497A (en) * | 2006-06-27 | 2007-12-19 | 张宏宇 | Composition containing lycopane and thioglycoside |
| CN101856120A (en) * | 2010-03-23 | 2010-10-13 | 无锡市天赐康生物科技有限公司 | Health food for improving immunity of human body and preparation method thereof |
| CN102078351A (en) * | 2011-01-07 | 2011-06-01 | 上海蟾宝生物科技有限公司 | Composition for treating cancer |
| CN102551058A (en) * | 2012-01-17 | 2012-07-11 | 北京东方红航天生物技术股份有限公司 | Chinese medicinal health-care product with function of enhancing immunity |
| CN102885311A (en) * | 2012-10-19 | 2013-01-23 | 中科乐仁（北京）科技发展有限公司 | Composite health food composition for alleviating physical fatigue and preparation method thereof |
| CN106723022A (en) * | 2016-11-29 | 2017-05-31 | 王政源 | A kind of sika deer velvet antler peacilomyce hepiahi bacterium capsule and preparation method thereof |
-
2018
- 2018-07-19 CN CN201810794340.4A patent/CN109077317A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101088497A (en) * | 2006-06-27 | 2007-12-19 | 张宏宇 | Composition containing lycopane and thioglycoside |
| CN101856120A (en) * | 2010-03-23 | 2010-10-13 | 无锡市天赐康生物科技有限公司 | Health food for improving immunity of human body and preparation method thereof |
| CN102078351A (en) * | 2011-01-07 | 2011-06-01 | 上海蟾宝生物科技有限公司 | Composition for treating cancer |
| CN102551058A (en) * | 2012-01-17 | 2012-07-11 | 北京东方红航天生物技术股份有限公司 | Chinese medicinal health-care product with function of enhancing immunity |
| CN102885311A (en) * | 2012-10-19 | 2013-01-23 | 中科乐仁（北京）科技发展有限公司 | Composite health food composition for alleviating physical fatigue and preparation method thereof |
| CN106723022A (en) * | 2016-11-29 | 2017-05-31 | 王政源 | A kind of sika deer velvet antler peacilomyce hepiahi bacterium capsule and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102392130B1 (en) | Pet Oral composition comprising Seaweed extracts and the Product comprising the same | |
| CN106266700A (en) | A kind of Fructus Hippophae prescription bag alveolitoid medicinal tea allotment and manufacture method | |
| CN101313756A (en) | Preparation method for health-care food | |
| CN103215149A (en) | Natural ecological loofah-sandwiched petal soap and preparation method of soap | |
| CN103520066A (en) | Edible natural propolis antibacterial toothpaste and preparation method thereof | |
| CN100594804C (en) | Compound rhodamine oil soft capsule and method for preparing the same | |
| CN114868847A (en) | Passion fruit sodium hyaluronate beverage and preparation method thereof | |
| CN107006840A (en) | A kind of Saussurea involucrata culture capsule and preparation method thereof | |
| CN104473910A (en) | Pregabalin sustained release pellets and preparation method thereof | |
| CN106616105A (en) | Lycium ruthenicum health-care beverage and preparation method thereof | |
| CN109077317A (en) | A kind of lycopene capsules and preparation method thereof | |
| CN101878899A (en) | Healthcare food composite and production method thereof | |
| CN101104015B (en) | Olive soft capsule raw material formulation and its preparation technology | |
| CN101904414A (en) | Chicken feed and method for processing eggs with Chinese medicinal tincture | |
| CN101971941A (en) | Preparation method of composite dendrobe health-care product | |
| CN104606092A (en) | Toothpaste capable of calming nerves and helping sleep for night use and preparation method thereof | |
| CN101396121B (en) | Preparation method of nutrient tonification food | |
| CN104432392A (en) | Heart-strengthening and aging-resisting blueberry solid particle beverage and preparation method thereof | |
| CN102150771A (en) | Anti-radiation bee product composite preparation and preparation method thereof | |
| CN105685485A (en) | Method for producing brain gold eggs | |
| CN103907922A (en) | Health food and production technology thereof | |
| CN102144698A (en) | Taraxacum tea | |
| CN103918826A (en) | Bathing scented tea particle packet and preparing method thereof | |
| CN105125443B (en) | Facial mask with tremella as main raw material and preparation method thereof | |
| CN101836732A (en) | Female health food composition and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181225 |
|
| RJ01 | Rejection of invention patent application after publication |